reported that blockage of FATP2 expression in MDSCs by lipofermata decreased lipid accumulation, lower ROS, blocked immunosuppressive activity, down-regulated PD-L1 expression on CD8+ TILs, and even enhanced anti-PD-L1 anti-tumor efficacy in murine model (136). The gene discussed is SLC27A2; the disease is neoplasm.